- Home
- ABEO vs RCAT Comparison
ABEO vs RCAT Comparison
Compare ABEO & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- RCAT
- Stock Information
- Founded
- ABEO N/A
- RCAT 2002
- Country
- ABEO United States
- RCAT United States
- Employees
- ABEO N/A
- RCAT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- RCAT Wholesale Distributors
- Sector
- ABEO Health Care
- RCAT Industrials
- Exchange
- ABEO Nasdaq
- RCAT Nasdaq
- Market Cap
- ABEO 277.6M
- RCAT 248.8M
- IPO Year
- ABEO 1980
- RCAT 2017
- Fundamental
- Price
- ABEO $6.54
- RCAT $3.50
- Analyst Decision
- ABEO Strong Buy
- RCAT Strong Buy
- Analyst Count
- ABEO 3
- RCAT 1
- Target Price
- ABEO $18.00
- RCAT $4.00
- AVG Volume (30 Days)
- ABEO 287.8K
- RCAT 2.2M
- Earning Date
- ABEO 11-11-2024
- RCAT 12-13-2024
- Dividend Yield
- ABEO N/A
- RCAT N/A
- EPS Growth
- ABEO N/A
- RCAT N/A
- EPS
- ABEO N/A
- RCAT N/A
- Revenue
- ABEO N/A
- RCAT $18,864,788.00
- Revenue This Year
- ABEO N/A
- RCAT $82.78
- Revenue Next Year
- ABEO $7,097.06
- RCAT N/A
- P/E Ratio
- ABEO N/A
- RCAT N/A
- Revenue Growth
- ABEO 147.52
- RCAT 259.85
- 52 Week Low
- ABEO $3.05
- RCAT $0.53
- 52 Week High
- ABEO $9.01
- RCAT $3.94
- Technical
- Relative Strength Index (RSI)
- ABEO 62.48
- RCAT 59.74
- Support Level
- ABEO $6.39
- RCAT $3.11
- Resistance Level
- ABEO $6.74
- RCAT $3.94
- Average True Range (ATR)
- ABEO 0.31
- RCAT 0.35
- MACD
- ABEO -0.01
- RCAT 0.05
- Stochastic Oscillator
- ABEO 79.59
- RCAT 72.50
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About RCAT Red Cat Holdings Inc.
Red Cat Holdings Inc is a military technology company that integrates robotic hardware and software to provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders. Its mission is to enhance the effectiveness and safety of military operations domestically and globally. Red Cat's suite of solutions includes Teal Drones, developer of the Golden Eagle, a small unmanned system with the highest resolution imaging for night-time operations, and Skypersonic, a provider of unmanned aircraft for interior spaces and other dangerous environments.